Mushroom Polysaccharide Eye Drops for Dry Eye Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current ophthalmic compositions fail to provide sustained relief for ocular discomfort, particularly for dry eye syndrome, and often contain preservatives that can irritate the eyes, lacking the natural benefits of the tear film.

Innovation Solution

Development of ophthalmic pharmaceutical compositions comprising polysaccharides extracted from mushrooms, specifically glucuronoxylomannan or variants, which remain on the ocular surface for an extended period, providing relief from discomfort caused by dry eye syndrome, allergies, infections, and inflammation without preservatives.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If preservatives are added to ophthalmic compositions to extend shelf life, then storage stability is improved, but eye irritation and harmful effects increase

Engineering Contradiction:
Improvestorage stabilityVSAvoideye irritation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent removes preservatives from the ophthalmic composition entirely, extracting the harmful substance while maintaining product stability through alternative means (sterile formulation and controlled packaging)

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The composition is formulated as a preservative-free single-use or limited-use product, accepting shorter in-use stability in exchange for eliminating preservative-related eye irritation

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Productivity

If conventional ophthalmic compositions are used, then immediate relief is provided, but duration of action is short-lived

Engineering Contradiction:
Improveimmediate reliefVSAvoidduration of relief
Core Design Contradiction:
ProductivityVSDuration of action of moving object

Solution Approach 1:

The patent changes the physical-chemical parameters of the composition by incorporating specific polymers and lipids that modify rheological properties, enabling the formulation to remain on the ocular surface longer while maintaining immediate comfort relief

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The composition uses a composite formulation combining polymers, lipids, and buffers that work synergistically to provide both immediate relief and extended duration of action on the ocular surface

Inventive Principle:
Principle #40Composite materials

3Ease of manufacture

If artificial tear compositions are formulated without natural tear film components, then manufacturing simplicity is improved, but effectiveness in providing natural tear benefits is reduced

Engineering Contradiction:
Improveformulation simplicityVSAvoideffectiveness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent modifies the formulation to include specific physiological components (polymers, lipids, buffers) that mimic natural tear film properties, enhancing effectiveness while maintaining manufacturing feasibility through well-established pharmaceutical ingredients

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polysaccharide compositions demonstrate enhanced viscosity, shear-thinning properties, and improved wetting ability, offering sustained relief and mucin interaction, effectively addressing dry eye syndrome and other ocular discomforts while being preservative-free.

Implementation Method 1

The polysaccharide compositions demonstrate enhanced viscosity, shear-thinning properties

Methodology Applied
Scientific EffectShear thinning: Shear Thinning

Implementation Method 2

offering sustained relief and mucin interaction

Methodology Applied
Scientific EffectMucin interaction: Adhesive

Data Source

PatentUS8859525B2Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
Publication Date: 2014.10.14 BAUSCH & LOMB INC
  • US8859525B2 patent drawing
  • US8859525B2 patent drawing
  • US8859525B2 patent drawing

AI summary

A composition for providing relief to a discomfort of an eye comprises a pharmaceutically acceptable carrier and a polysaccharide extracted from a plant source. In certain embodiments, such a polysaccharide can be extracted from mushrooms, such as from the Tremella fuciformis species. The composition is administered to an affected eye to provide such relief or discomfort.